American Journal of Psychiatry · 1990 · 193 citations · 36 references
PharmacyPharmacotherapyPsychiatryAdult PsychiatryPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyOutpatient PsychiatrySchizophrenia PharmacotherapyTreatment Of Mental DisordersAntipsychotic Medication ManagementAntipsychotic Medication UseMedication AdministrationMedication Burden ReductionSingle-blind Trials
The study enrolled 116 chronic schizophrenia outpatients in a 2‑year single‑blind trial comparing continuous versus targeted medication, without restricting participants to those suitable for reduction. Continuous medication outperformed targeted medication by reducing decompensations, hospitalizations, and improving employment at 2 years, while other psychopathology and functioning measures were similar and the targeted approach lowered overall medication use.
The authors report on the outcome of treatment of 116 outpatients with chronic schizophrenia who were assigned to a 2-year, single-blind course of treatment with either targeted or continuous medication. These patients were not restricted to those who were good candidates for a medication reduction strategy. Continuous medication was superior to targeted medication in preventing decompensations and hospitalizations and in extent of employment at 2 years. Other measures of psychopathology and functioning at 1 and 2 years did not differentiate the two groups of patients. The targeted approach achieved a substantial reduction in total medication through a reduction in the number of days of medication administration.
36
Jean Endicott · Archives of General Psychiatry · 1976 · 5K citations
The Early Symptoms of Schizophrenia
James Chapman · The British Journal of Psychiatry · 1966 · 675 citations